Simulation of Clinical Trials
- 1 April 2000
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 40 (1), 209-234
- https://doi.org/10.1146/annurev.pharmtox.40.1.209
Abstract
Computer simulation of clinical trials has evolved over the past two decades from a simple instructive game to “full” simulation models yielding pharmacologically sound, realistic trial outcomes. The need to make drug development more efficient and informative and the awareness that many industries make extensive use of simulation in product development have advanced considerably the use of simulation of clinical trials in pharmaceutical product development over the past decade. The structural and stochastic components of trial simulation models are explained as a prelude to a listing of representative simulation projects, reflecting investigative applications of statistical methods, trial design comparisons, and full simulation of new drugs being developed. Lessons learned from these projects are reviewed in the context of their current impact and potential for influencing the future of drug development.Keywords
This publication has 38 references indexed in Scilit:
- The importance of modeling interoccasion variability in population pharmacokinetic analysesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporineJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Population Pharmacokinetics of Procainamide from Routine Clinical DataClinical Pharmacokinetics, 1984
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Simultaneous pharmacokinetic and pharmacodynamic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease.Circulation, 1980